Low-risk patients with gestational trophoblastic disease (GTD) are initially treated with methotrexate (MTX)/folinic acid (FA) as this regimen is well tolerated and has no long-term sequelae.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results